Back to search

Article

SARS-CoV-2 Spike S1 glycoprotein is a TLR4 agonist, upregulates ACE2 expression and induces pro-inflammatory M <sub>1</sub> macrophage polarisation

2021-08-11

Abstract excerpt

<h4>Background and aims</h4> TLR4 is an important innate immune receptor that recognizes bacterial LPS, viral proteins and other pathogen associated molecular patterns (PAMPs). It is expressed on tissue-resident and immune cells. We previously proposed a model whereby SARS-CoV-2 activation of TLR4 via its spike glycoprotein S1 domain increases ACE2 expression, viral loads and hyperinflammation with COVID-19 disea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
efe799e8-3f5c-57c0-b6cd-318fff38612c
DOI
10.1101/2021.08.11.455921
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 Spike S1 glycoprotein is a TLR4 agonist, upregulates ACE2 expression and induces pro-inflammatory M <sub>1</sub> macrophage polarisationDOI 10.1101/2021.08.11.455921
Select a neighboring publication to make it the new centre.